Expression of Lung Surfactant Proteins SP-B and SP-C and Their Regulatory Factors in Fetal Lung of GDM Rats

Abstract

This study investigated the expression of lung surfactant proteins (SP-B and SP-C), and regulatory factors [forkhead box A2 (FOXA2) and nitrolyogenic FOXA2 (N-FOXA2)] in the fetal lung of rats with gestational diabetes mellitus (GDM) in order to study the mechanism of pulmonary dysplasia. The rat GDM model was established by using streptozotocin intraperitoneally in the first stage of pregnancy. There were 10 rats in the GDM group, and 10 healthy rats in normal control group without any treatment. Fetal lungs of two groups were taken at day 21 of pregnancy. Blood glucose levels of maternal rats and fetal rats were measured by Roche blood glucose meter. The histological changes in the fetal lung were observed under the light microscope in both groups. The SP-B, SP-C and FOXA2 were determined in the fetal lung of two groups immunohistochemically. The expression levels of SP-B, SP-C, total FOXA2, FOXA2 in nucleus (n-FOXA2), N-FOXA2 proteins were detected by Western blotting, and the relative expression levels of SP-B, SP-C, FOXA2 mRNA in the fetal lung of two groups were detected by RTPCR. The results showed that blood glucose levels of maternal rats and fetal rats in GDM group were higher than those in control group. The light microscope revealed fetal lung development retardation in GDM group. The expression of SP-B and SP-C in GDM group was significantly reduced as compared with control group (P<0.05). As compared with control group, the n-FOXA2 expression was significantly decreased in the fetal lung tissue, and N-FOXA2 was significantly increased in control group (P<0.05), but there was no significant changes in the total FOXA2 (P>0.05). It was concluded that GDM can cause fetal lung development and maturation disorders, and FOXA2 in fetal lung tissue decreases while nitrocellulose FOXA2 increases.

Keywords

nitrolyogenic FOXA2 / fetal lung development / gestational diabetes mellitus

References

[1] MorriseyEE, HoganBL. Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell, 2010, 18(1): 8-23

[2] WolfrumC, AsilmazE, LucaE, et al.. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature, 2004, 432(7020): 1027-1032

[3] JimenezFR, BelgiqueST, LewisJB, et al.. Conditional pulmonary over-expression of Claudin 6 during embryogenesis delays lung morphogenesis. Int J Dev Biol, 2015, 59(10–12): 479-485

[4] SunL, TangXJ, LuoFM. Forkhead box protein A2 and T helper type 2-mediated pulmonary inflammation. World J Methodol, 2015, 5(4): 223-229

[5] Ortega-SenovillaH, Schaefer-GrafU, MeitznerK, et al.. Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care, 2011, 34(9): 2061-2066

[6] VignolesP, GireC, ManciniJ, et al.. Gestational diabetes: a strong independent risk factor for severe neonatal respiratory failure after 34 weeks. Arch Gynecol Obstet, 2011, 284(5): 1099-1104

[7] CatalanoPM, McIntyreHD, CruickshankJK, et al.. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care, 2012, 35(4): 780-786

[8] FungGP, ChanLM, HoYC, et al.. Does gestational diabetes mellitus affect respiratory outcome in latepreterm infants. Early Hum Dev, 2014, 90(9): 527-530

[9] YangP, CaoY, LiH. Hyperglycemia induces inducible nitric oxide synthase gene expression and consequent nitrosative stress via c-Jun N-terminal kinase activation. Am J Obstet Gynecol, 2010, 203(2): 5-11

[10] KurtzM, MartinezN, CapobiancoE, et al.. Increased nitric oxide production and gender-dependent changes in PPARalpha expression and signaling in the fetal lung from diabetic rats. Mol Cell Endocrinol, 2012, 362(1–2): 120-127

[11] HaoY, KuangZ, XuY, et al.. Pyocyanin-induced mucin production is associated with redox modification of FOXA2. Respir Res, 2013, 14: 82

[12] DengFT, ZhangL, GeLF, et al.. Fetal lung structures and expression of pulmonary surfactant proteins of B and C and their modulating factors in rat with gestational diabetes mellitus. Chin J Perinatal Med (Chinese), 2015, 18(8): 625-631

[13] ReesDA, AlcoladoJC. Animal models of diabetes mellitus. Diabet Med, 2005, 22(4): 359-370

[14] WarburtonD. Overview of Lung Development in the Newborn Human. Neonatology, 2017, 111(4): 398-401

[15] JimenezFR, LewisJB, BelgiqueST, et al.. Developmental lung expression and transcriptional regulation of claudin-6 by TTF-1, Gata-6, and FoxA2. Respir Res, 2014, 15: 70

[16] WhitsettJA, MatsuzakiY. Transcriptional regulation of perinatal lung maturation. Pediatr Clin North Am, 2006, 53(5): 873-887

[17] ChungC, KimT, KimM, et al.. Hippo-Foxa2 signaling pathway plays a role in peripheral lung maturation and surfactant homeostasis. Proc Natl Acad Sci USA, 2013, 110(19): 7732-7737

[18] WanH, XuY, IkegamiM, et al.. Foxa2 is required for transition to air breathing at birth. Proc Natl Acad Sci USA, 2004, 101(40): 14 449-14 454

[19] WanH, KaestnerKH, AngSL, et al.. Foxa2 regulates alveolarization and goblet cell hyperplasia. Development, 2004, 131(4): 953-964

[20] MavromatakisYE, LinW, MetzakopianE, et al.. Foxa1 and Foxa2 positively and negatively regulate Shh signalling to specify ventral midbrain progenitor identity. Mech Dev, 2011, 128(1–2): 90-103

[21] WanH, DingleS, XuY, et al.. Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis. J Biol Chem, 2005, 280(14): 13 809-13 816

[22] DengFT, OuyangWX, GeLF, et al.. Expression of lung surfactant proteins SP-B and SP-C and their modulating factors in fetal lung of FGR rats. J Huazhong Univ Sci Technolog Med Sci, 2015, 35(1): 122-128

[23] HuaKF, WangSH, DongWC, et al.. High glucose increases nitric oxide generation in lipopolysaccharide-activated macrophages by enhancing activity of protein kinase C-alpha/delta and NF-kappaB. Inflamm Res, 2012, 61(10): 1107-1116

[24] KurtzM, CapobiancoE, CareagaV, et al.. Peroxisome proliferator-activated receptor ligands regulate lipid content, metabolism, and composition in fetal lungs of diabetic rats. J Endocrinol, 2014, 220(3): 345-359